Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AZIN1 antisense RNA 2 is a long non-coding RNA gene transcribed from the genomic locus antisense to the protein-coding AZIN1 gene. As with many lncRNAs, AZIN1-AS2 may regulate the expression of its sense mRNA partner (AZIN1) through RNA-RNA interactions, transcriptional interference, or epigenetic modification. Functional and mechanistic evidence specifically for AZIN1-AS2 is limited, and it is not widely recognized as a direct therapeutic target. The most prominent research on the AZIN1 locus concerns the protein-coding gene (AZIN1), which is involved in polyamine regulation, RNA editing, and several cancers; these findings do not directly translate to AZIN1-AS2.
None established for drugs (since no drug targets are known). General lncRNA mechanisms may involve RNA-RNA binding or chromatin interactions regulating sense gene expression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AZIN1 antisense RNA 2 (AZIN1-AS2).